Review Articles/Book Chapters

1. Borthakur A, Venugopal KN, Thummer RP (2025) Leveraging cardiac reprogramming with CRISPRa-SAM technology. Mol Ther Nucleic Acids; 36(2): 102532. https://doi.org/10.1016/j.omtn.2025.102532 (IF: 6.5)

2. Karmakar, A., Augustine, A. B. H. R., & Thummer, R. P. (2025). Genes as genome stabilizers in pluripotent stem cells. In Cell Biology and Translational Medicine (Sub-series), Advances in Experimental Medicine and Biology (Springer Nature). Springer Nature (IF: 3.65)

3. Raj, N., Karmakar, A., Narayan, G., & Thummer, R. P. (2025). Small molecules and epigenetic modifiers in facilitating pancreatic β-cell formation: A comprehensive insight. In Cell Biology and Translational Medicine (Sub-series), Advances in Experimental Medicine and Biology (Springer Nature). Springer Nature (IF: 3.65)

4. Sundaravadivelu, P. K., Borthakur, A., Agrawal, A., Sen, T., & Thummer, R. P. (2025). An Overview of the Generation of Integration-free Induced Pluripotent Stem Cells and Their Subsequent Differentiation into Cardiomyocytes and β-cells. Stem Cell Biology: A Regenerative Tissue Perspective, 95-149 (IF: 4.1)

5. Ronima KR, Dey C, Thummer RP (2023) An insight into the role of GLIS1 in embryonic development, iPSC generation and cancer. Sub-series: Cell Biology and Translational Medicine. Series: Advances in Experimental Medicine and Biology (Springer Nature), (IF: 3.650)

6. Narayan G, Ronima KR, Agrawal A, Thummer RP (2023) An insight into vital genes responsible for β-cell formation. Sub-series: Cell Biology and Translational Medicine. Series: Advances in Experimental Medicine and Biology (Springer Nature), (IF: 3.650)

7. Haridhasapavalan KK, Borthakur A, Thummer RP (2023) Direct cardiac reprogramming: Current status and future prospects. Sub-series: Cell Biology and Translational Medicine. Series: Advances in Experimental Medicine and Biology (Springer Nature), (IF: 3.650)

8. Mehak, Thummer RP, Pandey, LM (2023) Surface modified iron-oxide based engineered nanomaterials for hyperthermia therapy of cancer cells. Biotechnology and Genetic Engineering Reviews (Taylor & Francis), (IF: 4.200).

9. Narayan G, Ronima KR, Thummer RP (2023) Direct reprogramming of somatic cells into induced β-cells: An Overview. Sub-series: Cell Biology and Translational Medicine. Series: Advances in Experimental Medicine and Biology (Springer Nature), (IF: 3.650)

10. Thummer RP, Kaveeshwar V, Nayanabhirama U (2023) Induced pluripotent stem cell biobanking: A future perspective for regenerative and personalized medicine. Bio Banking for Affordable Healthcare Practices and Research. Manipal University Press. ISBN: 978-8195573028. Invited Book Chapter.

11. Sen T, Thummer RP (2022) CRISPR and iPSCs: Recent developments and future perspectives in neurodegenerative disease modelling, research and therapeutics. Neurotoxicity Research (Springer Nature), (IF: 3.978)

12. Sen T, Thummer RP (2022) The impact of human microbiotas in hematopoietic stem cell and organ transplantation. Frontiers in Immunology; Section: Microbial Immunology (Frontiers), (IF: 8.786)

13. Thool M, Sundaravadivelu PK, Sudhagar S, Thummer RP (2022) A comprehensive review on the role of ZSCAN4 in embryonic development, stem cells, and cancer. Stem Cell Reviews and Reports 18, 2740–2756 (Springer Nature), (IF: 6.692)

14. Dey C*, Raina K*, Thool M*, Adhikari P, Haridhasapavalan KK, Sundaravadivelu PK, Venkatesan V, Gogoi R, Sudhagar S, Thummer RP (2022) Auxiliary pluripotency-associated genes and their contributions in the generation of induced pluripotent stem cells. Molecular Players in iPSC Technology, Volume 12. Elsevier: Academic Press. ISBN: 9780323900591; 29-94. *Equal contribution, Invited Book Chapter.

15. Sundaravadivelu PK, Raina K, Thool M, Ray A, Joshi JM, Kaveeshwar V, Sudhagar S, Lenka N, Thummer RP (2021) Tissue-restricted stem cells as starting cell source for efficient generation of pluripotent stem cells: An overview. In: Turksen K. (eds) Cell Biology and Translational Medicine, Volume 15. Advances in Experimental Medicine and Biology (Springer Nature), (IF: 3.650)

16. Ray A*, Joshi JM*, Sundaravadivelu PK*, Raina K, Lenka N, Kaveeshwar V, Thummer RP (2021) An overview on promising somatic cell sources utilized for the efficient generation of induced pluripotent stem cells. Stem Cell Reviews and Reports. 17, 1954–1974. (Springer Nature), *Equal contribution, (IF: 6.692)

17. Agrawal A*, Narayan G*, Gogoi R, Thummer RP (2021) Recent advances in the generation of β-cells from induced pluripotent stem cells as a potential cure for diabetes mellitus. In: Turksen K. (eds) Cell Biology and Translational Medicine, Volume 14. Advances in Experimental Medicine and Biology (Springer Nature), *Equal contribution. (IF: 3.650)

18. Raina K, Dey C, Thool M, Sudhagar S, Thummer RP (2021) An insight into the role of UTF1 in development, stem cells, and cancer. Stem Cell Reviews and Reports, 17: 1280-1293 (Springer Nature), (IF: 6.692)

19. Dey C*, Raina K*, Haridhasapavalan KK*, Thool M*, Sundaravadivelu PK, Adhikari P, Gogoi R, Thummer RP (2021) An Overview of reprogramming approaches to derive integration-free induced pluripotent stem cells for prospective biomedical applications. Recent Advances in iPSC Technology, Volume 5 in Advances in Stem Cell Biology. Elsevier: Academic Press. ISBN: 9780128222317; 231-287 *Equal contribution, Invited Book Chapter.

20. Haridhasapavalan KK*, Raina K*, Dey C*, Adhikari P, Thummer RP (2020) An insight into reprogramming barriers to iPSC generation. Stem Cell Reviews and Reports, 16(1): 56-81 (Springer Nature), *Equal contribution. (IF: 6.692)

21. Borgohain MP*, Haridhasapavalan KK*, Dey C, Adhikari P, Thummer RP (2019) An insight into DNA-free reprogramming approaches to generate integration-free induced pluripotent stem cells for prospective biomedical applications. Stem Cell Reviews and Reports 15(2): 286-313 (Springer Nature), *Equal contribution. (IF: 6.692)

22. Haridhasapavalan KK*, Borgohain MP*, Dey C, Saha B, Narayan G, Kumar S, Thummer RP (2019) An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells. Gene 686: 146-159 (Elsevier), *Equal contribution. (IF: 3.913)

23. Saha B, Krishna Kumar H, Borgohain MP, Thummer RP (2018) Prospective applications of induced pluripotent stem cells in military medicine. Medical Journal Armed Forces India 74(4): 313-320 (Elsevier), (IF: 0.50)

24. Saha B, Borgohain MP, Dey C, Thummer RP (2018) iPS cell generation: current and future challenges. Annals of Stem Cell Research and Therapy 1(2): 1007. Invited Mini Review Article.

25. Borgohain MP*, Narayan G*, Krishna Kumar H, Dey C, Thummer RP (2018) Maximizing expression and yield of human recombinant proteins from bacterial cell factories for biomedical applications. Advances in Microbial Biotechnology: Current Trends and Future Prospects. Apple Academic Press. ISBN: 9781771886673; 431-468. *Equal contribution, Invited Book Chapter.

26. Dey C*, Narayan G*, Krishna Kumar H*, Borgohain MP*, Lenka N, Thummer RP (2017) Cell-penetrating peptides as a tool to deliver biologically active recombinant proteins to generate transgene-free induced pluripotent stem cells. Studies on Stem Cells Research and Therapy 3(1): 006-015 (Peertechz), *Equal contribution, Invited Review Article.

$ Corresponding authors.

* These authors have contributed equally to this manuscript.

Impact factor (IF) based on year 2023 (Clarivate Analytics).